chlorambucil has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demopoulos, NA; Efthimiou, M; Nikolaropoulos, SS; Stephanou, G | 1 |
1 other study(ies) available for chlorambucil and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Aneugenic potential of the anticancer drugs melphalan and chlorambucil. The involvement of apoptosis and chromosome segregation regulating proteins.
Topics: Amino Acid Chloromethyl Ketones; Animals; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Blotting, Western; Centrosome; Chlorambucil; Chromosome Breakage; Chromosome Segregation; Fibroblasts; Fluorescent Antibody Technique; Inhibitor of Apoptosis Proteins; Melphalan; Mice; Microscopy, Fluorescence; Microtubules; Neuroprotective Agents; Propidium; Protein Serine-Threonine Kinases; Repressor Proteins; Survivin; Tubulin | 2013 |